These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 28382372

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
    MacLeod TJ, Kwon M, Filipenko NR, Waisman DM.
    J Biol Chem; 2003 Jul 11; 278(28):25577-84. PubMed ID: 12730231
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11.
    He KL, Deora AB, Xiong H, Ling Q, Weksler BB, Niesvizky R, Hajjar KA.
    J Biol Chem; 2008 Jul 11; 283(28):19192-200. PubMed ID: 18434302
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells.
    Zhang L, Fogg DK, Waisman DM.
    J Biol Chem; 2004 Jan 16; 279(3):2053-62. PubMed ID: 14570893
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity.
    Bydoun M, Waisman DM.
    Future Oncol; 2014 Dec 16; 10(15):2469-79. PubMed ID: 25525855
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
    Sharma MC, Sharma M.
    Curr Pharm Des; 2007 Dec 16; 13(35):3568-75. PubMed ID: 18220793
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of the annexin A2 heterotetramer in vascular fibrinolysis.
    Madureira PA, Surette AP, Phipps KD, Taboski MA, Miller VA, Waisman DM.
    Blood; 2011 Nov 03; 118(18):4789-97. PubMed ID: 21908427
    [Abstract] [Full Text] [Related]

  • 17. The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis.
    Madureira PA, O'Connell PA, Surette AP, Miller VA, Waisman DM.
    J Biomed Biotechnol; 2012 Nov 03; 2012():353687. PubMed ID: 23118506
    [Abstract] [Full Text] [Related]

  • 18. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.
    Kassam G, Le BH, Choi KS, Kang HM, Fitzpatrick SL, Louie P, Waisman DM.
    Biochemistry; 1998 Dec 01; 37(48):16958-66. PubMed ID: 9836589
    [Abstract] [Full Text] [Related]

  • 19. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
    Sharma MR, Rothman V, Tuszynski GP, Sharma MC.
    Exp Mol Pathol; 2006 Oct 01; 81(2):136-45. PubMed ID: 16643891
    [Abstract] [Full Text] [Related]

  • 20. The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.
    Bharadwaj AG, Kempster E, Waisman DM.
    Biomolecules; 2021 Nov 26; 11(12):. PubMed ID: 34944416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.